NCT00912808View on ClinicalTrials.gov

Cholinergic Augmentation in Frequently Falling Subjects With Parkinson's Disease

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Parkinson's Disease
Interventions
DRUG

Donepezil

donepezil, 5 mg, capsule, once a day, 3 weeks

DRUG

Sugar Pill (placebo)

sugar pill, one capsule, once a day, 3 weeks

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT00912808 - Cholinergic Augmentation in Frequently Falling Subjects With Parkinson's Disease | Biotech Hunter | Biotech Hunter